Skip to main content

We’ve updated our Terms & Conditions and Privacy Policy. By using this site, you agree to these terms.

Diagnostic excellence leads to early detection of life-threatening disease

DANVILLE, Pa. – Geisinger vascular laboratories across the system recently earned testing reaccreditation from the Intersocietal Accreditation Commission (IAC). 

Vascular ultrasound is used to diagnose diseases of the blood vessels in all parts of the body except the brain and heart. It is essential to the early detection of life-threatening conditions like carotid artery disease, peripheral artery disease, intestinal artery disease, renal artery blockage, abdominal aneurysms and blood clots. 

Early diagnosis and treatment of these conditions helps prevent potentially deadly or disabling complications like stroke, ruptured aneurysms and limb amputation. 

The IAC grants three-year accreditation in the areas of extracranial cerebrovascular testing, peripheral venous testing, visceral vascular testing and peripheral arterial testing. Accreditation provides reassurance for patients that a vascular laboratory delivers consistent, quality care and is dedicated to continuous improvement.  

Accreditation means:
A facility has undergone a thorough review of its operational and technical components by a panel of experts in the field.
A facility upholds processes that comply with national standards.
A facility has standards in place for patient and personnel safety. 

“This accreditation is a testament to the hard work and commitment of our vascular diagnostic teams across the system,” said James Elmore, M.D., chair of Geisinger’s Department of Vascular Surgery. “Geisinger has a long history of excellence in vascular diagnostics and treatment, and we’re proud to maintain accreditation from an organization that holds the same high standards.”

Accredited Geisinger vascular laboratories:
Geisinger Healthplex State College, Geisinger Medical Center and Geisinger Lewistown Hospital for extracranial cerebrovascular testing, peripheral venous testing, visceral vascular testing and peripheral arterial testing

Geisinger Community Medical Center, Geisinger Lewistown, Geisinger Mifflintown, Geisinger Mount Pocono, Geisinger South Wilkes-Barre, Geisinger Tunkhannock and Geisinger Wyoming Valley Medical Center for extracranial cerebrovascular testing, peripheral venous testing and peripheral arterial testing

Geisinger Phillipsburg for extracranial cerebrovascular testing
 

About Geisinger

Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across central and northeastern Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the nonprofit system generates more than $8 billion in annual revenues across 163 care sites — including 10 hospital campuses — and Geisinger Health Plan, with more than half a million members in commercial and government plans. Geisinger College of Health Sciences educates more than 500 medical professionals annually and is conducting more than 1,400 clinical research studies. With more than 27,000 employees, including 1,800 employed physicians and 5,200 registered nurses, Geisinger is among Pennsylvania’s largest employers, having an estimated economic impact of $16.8 billion on the state’s economy. In 2024, Geisinger joined Risant Health, a nonprofit charitable organization created to expand and accelerate value-based care across the country. Learn more at geisinger.org or follow on Facebook, Instagram and LinkedIn.

Geisinger Logo

For media inquires:

R. Matthew Mattei
Regional Strategist - Northeast

570-881-0817
rmmattei1@geisinger.edu

Content from General Links with modal content